GAS6 and systemic inflammatory response syndrome: We have measured the Gas6 and sAxl plasma concentrations in a large cohort of patients with severe sepsis, sepsis, milder infections, and SIRS without infection, and found that Gas6 increases in all patient groups, and the concentration correlates with disease severity and organ dysfunction.